• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带既往史预测产超广谱β-内酰胺酶肠杆菌科导致的重症监护病房感染。

Prior Carriage Predicts Intensive Care Unit Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.

机构信息

Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana.

Tropical Biome and Immunophysiopathology (TBIP), Universite de Guyane, Cayenne, French Guiana.

出版信息

Am J Trop Med Hyg. 2022 Jan 10;106(2):525-531. doi: 10.4269/ajtmh.20-1436.

DOI:10.4269/ajtmh.20-1436
PMID:35008044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8832904/
Abstract

Intensive care unit-acquired infection (ICU-AI) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage are a major concern worldwide. Our objective was to investigate the impact of ESBL-PE carriage on ICU-AI. Our study was prospective, observational, and noninterventional. It was conducted over a 5-year period (Jan 2013-Dec 2017) in the medical-surgical intensive care unit of the Cayenne General Hospital (French Amazonia). During the study period, 1,340 patients were included, 271 (20.2%) developed ICU-AI, and 16.2% of these were caused by ESBL-PE. The main sites of ICU-AI were ventilator-associated pneumonia (35.8%) and primary bloodstream infection (29.8%). The main responsible microorganisms were Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae (ESBL-P in 35.8% of isolates), and Enterobacter cloacae (ESBL-P in 29.8% of isolates). Prior ESBL-PE carriage was diagnosed in 27.6% of patients with ICU-AI. In multivariable analysis, the sole factor associated with ESBL-PE as the responsible organism of ICU-AI was ESBL-PE carriage before ICU-AI (P < 0.001; odds ratio: 7.9 95% CI: 3.4-18.9). ESBL-PE carriers (74 patients) developed ICU-AI which was caused by ESBL-PE in 32 cases (43.2%). This proportion of patients carrying ESBL-PE who developed ICU-AI to the same microorganism was 51.2% in ESBL-P K. pneumoniae, 5.6% in ESBL-P Escherichia coli, and 40% in ESBL-P Enterobacter spp. NPV of ESBL-PE carriage to predict ICU-AI caused by ESBL-PE was above 94% and PPV was above 43%. Carriage of ESBL-P K pneumoniae and Enterobacter spp. is a strong predictor of ICU-AI caused by these two microorganisms.

摘要

重症监护病房获得性感染(ICU-AI)和产超广谱β-内酰胺酶肠杆菌科(ESBL-PE)定植是全球关注的主要问题。我们的目的是研究 ESBL-PE 定植对 ICU-AI 的影响。我们的研究是前瞻性、观察性和非干预性的。它在卡宴综合医院(法属亚马逊地区)的内科-外科重症监护病房进行了 5 年(2013 年 1 月至 2017 年 12 月)。在研究期间,纳入了 1340 名患者,其中 271 名(20.2%)发生 ICU-AI,其中 16.2%是由 ESBL-PE 引起的。ICU-AI 的主要部位是呼吸机相关性肺炎(35.8%)和原发性血流感染(29.8%)。主要的致病微生物是金黄色葡萄球菌、铜绿假单胞菌、肺炎克雷伯菌(ESBL-P 在 35.8%的分离株中)和阴沟肠杆菌(ESBL-P 在 29.8%的分离株中)。在 27.6%的 ICU-AI 患者中诊断出先前存在 ESBL-PE 定植。在多变量分析中,唯一与 ESBL-PE 作为 ICU-AI 致病微生物相关的因素是 ICU-AI 前 ESBL-PE 定植(P < 0.001;优势比:7.995%CI:3.4-18.9)。ESBL-PE 携带者(74 名患者)发生了 ICU-AI,其中 32 例(43.2%)由 ESBL-PE 引起。携带 ESBL-PE 的患者发展为相同微生物引起的 ICU-AI 的比例为 ESBL-P K. pneumoniae 51.2%、ESBL-P Escherichia coli 5.6%和 ESBL-P Enterobacter spp. 40%。ESBL-PE 定植预测 ESBL-PE 引起的 ICU-AI 的阴性预测值(NPV)大于 94%,阳性预测值(PPV)大于 43%。ESBL-P K pneumoniae 和 Enterobacter spp. 的定植是这两种微生物引起的 ICU-AI 的强预测因素。

相似文献

1
Prior Carriage Predicts Intensive Care Unit Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.携带既往史预测产超广谱β-内酰胺酶肠杆菌科导致的重症监护病房感染。
Am J Trop Med Hyg. 2022 Jan 10;106(2):525-531. doi: 10.4269/ajtmh.20-1436.
2
Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.法国医院中产 ESBL 肠杆菌科的携带情况:PORTABLSE 研究。
J Hosp Infect. 2018 Mar;98(3):247-252. doi: 10.1016/j.jhin.2017.11.022. Epub 2017 Dec 6.
3
Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Carriage in Patients Admitted to Intensive Care Unit in a Tertiary Care Hospital in Thailand.泰国一家三级医院重症监护病房患者中产超广谱β-内酰胺酶肠杆菌科定植的危险因素。
Microb Drug Resist. 2019 Oct;25(8):1182-1190. doi: 10.1089/mdr.2018.0318. Epub 2019 May 29.
4
Epidemiology and Prognosis of Intensive Care Unit-Acquired Bloodstream Infection.重症监护病房获得性血流感染的流行病学和预后。
Am J Trop Med Hyg. 2020 Jul;103(1):508-514. doi: 10.4269/ajtmh.19-0877. Epub 2020 Apr 16.
5
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?重症监护病房患者中产超广谱β-内酰胺酶肠杆菌科细菌的定植与感染:对预后及碳青霉烯类药物暴露有何影响?
J Antimicrob Chemother. 2016 Apr;71(4):1088-97. doi: 10.1093/jac/dkv423. Epub 2016 Jan 10.
6
Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit.心胸重症监护病房中由产超广谱β-内酰胺酶的阴沟肠杆菌引起的医院感染暴发。
J Clin Microbiol. 2007 Aug;45(8):2365-9. doi: 10.1128/JCM.02546-06. Epub 2007 Jun 20.
7
Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.重症监护病房中产超广谱β-内酰胺酶细菌定植的临床影响和危险因素。
Intensive Care Med. 2012 Nov;38(11):1769-78. doi: 10.1007/s00134-012-2675-0. Epub 2012 Aug 15.
8
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.肝移植受者术前产超广谱β-内酰胺酶肠杆菌科细菌粪便携带相关的危险因素。
Transpl Infect Dis. 2014 Feb;16(1):84-9. doi: 10.1111/tid.12169. Epub 2013 Dec 16.
9
Fecal carriage of extended-spectrum beta-lactamase and ampc beta-lactamase-producing enterobacteriaceae in a turkish community.土耳其某社区中产超广谱β-内酰胺酶和产AmpCβ-内酰胺酶肠杆菌科细菌的粪便携带情况
Niger J Clin Pract. 2018 Jan;21(1):81-86. doi: 10.4103/njcp.njcp_79_17.
10
Extended spectrum beta-lactamase producing faecal carriage in a medical intensive care unit: low rates of cross-transmission and infection.产超广谱β-内酰胺酶的肠道定植:在医疗重症监护病房中交叉传播和感染的发生率较低。
Antimicrob Resist Infect Control. 2019 Jul 10;8:112. doi: 10.1186/s13756-019-0572-9. eCollection 2019.

引用本文的文献

1
Genetic characteristics and risk factors of extended-spectrum β-lactamase-producing in Chinese intensive care unit: a prospective molecular epidemiology study.中国重症监护病房产超广谱β-内酰胺酶细菌的遗传特征及危险因素:一项前瞻性分子流行病学研究
Microbiol Spectr. 2025 Aug 5;13(8):e0289524. doi: 10.1128/spectrum.02895-24. Epub 2025 Jul 15.
2
Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness.危重病中肠道微生物失调的发病机制和治疗机会。
Gut Microbes. 2024 Jan-Dec;16(1):2351478. doi: 10.1080/19490976.2024.2351478. Epub 2024 May 23.
3
Impact of Antibiotic Consumption on the Acquisition of Extended-Spectrum β-Lactamase Producing Carriage during the COVID-19 Crisis in French Guiana.

本文引用的文献

1
Critical care medicine in the French Territories in the Americas: Current situation and prospects.美洲法属领地的重症医学:现状与展望。
Rev Panam Salud Publica. 2021 Apr 28;45:e46. doi: 10.26633/RPSP.2021.46. eCollection 2021.
2
Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis.医院和重症监护病房获得性脓毒症的流行病学和负担:系统评价和荟萃分析。
Intensive Care Med. 2020 Aug;46(8):1536-1551. doi: 10.1007/s00134-020-06106-2. Epub 2020 Jun 26.
3
Epidemiology and Prognosis of Intensive Care Unit-Acquired Bloodstream Infection.
法属圭亚那新冠疫情期间抗生素使用对产超广谱β-内酰胺酶携带者感染的影响
Antibiotics (Basel). 2022 Dec 29;12(1):58. doi: 10.3390/antibiotics12010058.
4
Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study.免疫抑制与重症监护病房获得性多重耐药菌定植及感染之间的关系:一项前瞻性多中心队列研究。
Intensive Care Med. 2023 Feb;49(2):154-165. doi: 10.1007/s00134-022-06954-0. Epub 2023 Jan 2.
重症监护病房获得性血流感染的流行病学和预后。
Am J Trop Med Hyg. 2020 Jul;103(1):508-514. doi: 10.4269/ajtmh.19-0877. Epub 2020 Apr 16.
4
Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.对咽喉和直肠拭子进行半定量培养,是预测机械通气的产超广谱β-内酰胺酶肠杆菌科细菌携带者发生产超广谱β-内酰胺酶肠杆菌科细菌呼吸机相关性肺炎的有效检测方法。
Intensive Care Med. 2020 Jun;46(6):1232-1242. doi: 10.1007/s00134-020-06029-y. Epub 2020 Apr 20.
5
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017.2017 年重症监护病房患者感染的患病率和结局。
JAMA. 2020 Apr 21;323(15):1478-1487. doi: 10.1001/jama.2020.2717.
6
Quantifying risk of disease due to extended-spectrum β-lactamase producing Enterobacteriaceae in patients who are colonized at ICU admission.定量评估 ICU 入院时定植 Extended-spectrum β-lactamase producing Enterobacteriaceae 的患者发生相关疾病的风险。
J Infect. 2020 May;80(5):504-510. doi: 10.1016/j.jinf.2020.02.023. Epub 2020 Mar 4.
7
Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review.是否仍有必要对重症监护病房中产超广谱β-内酰胺酶肠杆菌科进行系统性粪便携带筛查:系统评价。
Crit Care. 2019 May 14;23(1):170. doi: 10.1186/s13054-019-2460-3.
8
Screening for Intestinal Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae in Critically Ill Patients: Expected Benefits and Evidence-based Controversies.危重症患者产超广谱β-内酰胺酶肠杆菌科细菌肠道携带筛查:预期获益与基于证据的争议
Clin Infect Dis. 2019 May 30;68(12):2125-2130. doi: 10.1093/cid/ciy864.
9
Relationship between digestive tract colonization and subsequent ventilator-associated pneumonia related to ESBL-producing Enterobacteriaceae.肠定植与产 ESBL 肠杆菌科相关呼吸机相关性肺炎的关系。
PLoS One. 2018 Aug 8;13(8):e0201688. doi: 10.1371/journal.pone.0201688. eCollection 2018.
10
Subsequent infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization.先前感染或粪便定植的患者中,后续感染产超广谱β-内酰胺酶肠杆菌科细菌。
Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1491-1497. doi: 10.1007/s10096-018-3275-x. Epub 2018 May 23.